|
Volumn 169, Issue 10, 2015, Pages 887-888
|
Global collaboration to develop new and existing drugs for neonates
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
NEW DRUG;
BRAIN INJURY;
DIGESTIVE SYSTEM INJURY;
DRUG CLEARANCE;
DRUG INDUSTRY;
EUROPEAN MEDICINES AGENCY;
GROUPS BY AGE;
HEALTH CARE ACCESS;
HEALTH CARE INDUSTRY;
HUMAN;
LUNG INJURY;
PERINATAL INFECTION;
PREMATURE LABOR;
PRIORITY JOURNAL;
QUALITY CONTROL;
RETROLENTAL FIBROPLASIA;
SHORT SURVEY;
STUDY DESIGN;
VOLUME OF DISTRIBUTION;
VULNERABLE POPULATION;
WITHDRAWAL SYNDROME;
WORLD HEALTH ORGANIZATION;
CLINICAL TRIAL (TOPIC);
COOPERATION;
DRUG DEVELOPMENT;
HEALTH;
INTERNATIONAL COOPERATION;
NEONATOLOGY;
NEWBORN;
PROCEDURES;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
DRUG DISCOVERY;
GLOBAL HEALTH;
HUMANS;
INFANT, NEWBORN;
INTERNATIONAL COOPERATION;
NEONATOLOGY;
|
EID: 84943386912
PISSN: 21686203
EISSN: 21686211
Source Type: Journal
DOI: 10.1001/jamapediatrics.2015.1640 Document Type: Short Survey |
Times cited : (24)
|
References (7)
|